Selection of optimal combinations of target genes for therapeutic multi-gene silencing based on miRNA co-regulation.

Malek, A; Gyorffy, B; Catapano, C V; Schäfer, R

Malek, A; Gyorffy, B; Catapano, C V; Schäfer, R.

Affiliation

Malek A; Laboratory of Oncoendocrinology, N.N.Petrov Institute of Oncology, Pesochny-2, St Petersburg, Russia. anastasia@malek.com

Cancer Gene Ther ; 20(5): 326-9, 2013 May.

Article in En | MEDLINE | ID: mdl-23618947

Subject(s)

Gene Expression/genetics; Gene Silencing; Genetic Therapy/methods; MicroRNAs/genetics; Ovarian Neoplasms/genetics; Ovarian Neoplasms/therapy; Female; Gene Expression Profiling; Humans; MicroRNAs/metabolism; Ovarian Neoplasms/metabolism; RNA Interference

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Genetic Therapy / Gene Expression / Gene Silencing / MicroRNAs Limits: Female / Humans Language: En Journal: Cancer Gene Ther Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google